Denovium Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Denovium General Information

Description

Developer of genome annotation and analytics software designed to accelerate innovation in biopharma. The company uses an AI-based approach for instant analysis and interpretation of large genomic data sets, allowing it to effectively support researchers in revolutionizing protein discovery by learning proteins at large.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 11646 Candy Rose Way
  • San Diego, CA 92131
  • United States
Primary Industry
Biotechnology
Acquirer
Corporate Office
  • 11646 Candy Rose Way
  • San Diego, CA 92131
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Denovium Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Denovium‘s full profile, request access.

Request a free trial

Denovium Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Denovium FAQs

  • When was Denovium founded?

    Denovium was founded in 2018.

  • Where is Denovium headquartered?

    Denovium is headquartered in San Diego, CA.

  • What is the size of Denovium?

    Denovium has 6 total employees.

  • What industry is Denovium in?

    Denovium’s primary industry is Biotechnology.

  • Is Denovium a private or public company?

    Denovium is a Private company.

  • What is Denovium’s current revenue?

    The current revenue for Denovium is .

  • When was Denovium acquired?

    Denovium was acquired on 12-Jan-2021.

  • Who acquired Denovium?

    Denovium was acquired by Absci.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »